First evidence of oncologic neuropathic pain prevalence after screening 8615 cancer patients. Results of the On study.
about
A retrospective study to identify risk factors for somnolence and dizziness in patients treated with pregabalinCan treatment success with 5% lidocaine medicated plaster be predicted in cancer pain with neuropathic components or trigeminal neuropathic pain?Poor efficacy of the phosphorylated high-molecular-weight neurofilament heavy subunit serum level, a biomarker of axonal damage, as a marker of chemotherapy-induced peripheral neuropathyAnalgesic effectiveness and tolerability of oral oxycodone/naloxone and pregabalin in patients with lung cancer and neuropathic pain: an observational analysisPatient Satisfaction with Spanish Pain Centers: Observational Study with More than 3,000 Patients.Procaine Attenuates Pain Behaviors of Neuropathic Pain Model Rats Possibly via Inhibiting JAK2/STAT3.Pharmacological treatment of neuropathic cancer pain: a comprehensive review of the current literature.Chronic diseases in the European Union: the prevalence and health cost implications of chronic pain.Cancer pain management: what's new?What is the evidence that neuropathic pain is present in chronic low back pain and soft tissue syndromes? An evidence-based structured review.Current use of drugs affecting the central nervous system for chemotherapy-induced peripheral neuropathy in cancer patients: a systematic review.Study protocol for a multi-institutional, randomised, double-blinded, placebo-controlled phase III trial investigating additive efficacy of duloxetine for neuropathic cancer pain refractory to opioids and gabapentinoids: the DIRECT study.Multicenter, cross-sectional observational study of the impact of neuropathic pain on quality of life in cancer patients.Opioids combined with antidepressants or antiepileptic drugs for cancer pain: Systematic review and meta-analysis.Pregabalin vs. opioids for the treatment of neuropathic cancer pain: a prospective, head-to-head, randomized, open-label study.The Prevalence of Neuropathic Pain in Terminally Ill Patients With Cancer Admitted to a Palliative Care Unit: A Prospective Observational Study.Lidocaine 5 % patches as an effective short-term co-analgesic in cancer pain. Preliminary results.Neuropathic cancer pain: prevalence, severity, analgesics and impact from the European Palliative Care Research Collaborative-Computerised Symptom Assessment study.The role of analgesic adjustment strategies in achieving analgesic efficacy in opioid-tolerant hospice patients in China.Association of Performance Status and Pain in Metastatic Bone Pain Management in the Spanish Clinical Setting.Can the LANSS scale be used to classify pain in chronic cancer pain trials?Efficacy and safety of pregabalin in patients with neuropathic cancer pain undergoing morphine therapy.Chemotherapy-induced neuropathic pain and its relation to cluster symptoms in breast cancer patients treated with paclitaxel.Prevalence of pain and relative diagnostic performance of screening tools for neuropathic pain in cancer patients: A cross-sectional study.Cancer-Related Pain: Prevalence, Severity and Management in a Tertiary Care Center in the Middle East
P2860
Q36507825-D2239707-49C3-439F-B191-5E1F49DC13BFQ36758278-E23737B0-05B2-453F-9598-3454559C7C18Q36953536-165BB932-8B45-4B37-A17A-427D8472FDA1Q37078524-2ACA3167-A3BE-48F4-868F-CC6D9BA582B7Q37144383-90664493-6E40-4862-8FCE-7DA62F6FCC6CQ37235249-8875C980-2B99-4B21-8474-D0E4D3BBA825Q37907386-390C17D3-A145-42E7-8833-5B0DE1DBD042Q38065255-085A65F1-18AB-4A04-BC19-8E44C14C9A21Q38086150-4BF67DDA-76B3-452D-9D13-3EB49C2E82A6Q38151940-6E3FE7B2-D9FE-4F25-AF38-E10B77B1F03EQ38254351-590EE715-4FFF-40BB-A1AA-01D59CF92C4EQ38603148-92EE31F3-AD5B-491C-8761-EDC40875A5C4Q38660867-62D76B76-4CE4-4A36-B53F-802EEA20E73EQ38730768-8238B021-0A8B-49CD-8925-82270522B974Q39231087-F9E0C05B-9621-441F-81B0-160E830D5E34Q41186667-F8472FB5-B513-429E-88A6-C998D98DA43DQ42616506-8A58934F-F511-434F-9FEF-188F2B04117EQ44003528-D3FCCAED-9EB5-45C2-BB30-C9684CA0DAC2Q44340219-0D717A01-511E-411A-9DF3-0C4CBC9C94F0Q47791538-0F0DF410-E8B9-461D-B92D-098E40D5E098Q47982872-7258EBE7-170D-485E-94F8-6451DB748995Q48006336-FD4A085F-5831-457E-82E6-ADCBFE4B4B61Q48247584-9D6EE200-FC04-4167-9F8F-92E118757FE7Q52838772-4E5377EA-6FB6-4C86-A322-EECAC4CE0B02Q55026211-23F0F50F-C523-49D5-9A6D-25807D8A7806
P2860
First evidence of oncologic neuropathic pain prevalence after screening 8615 cancer patients. Results of the On study.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
First evidence of oncologic ne ...... ents. Results of the On study.
@en
First evidence of oncologic ne ...... ents. Results of the On study.
@nl
type
label
First evidence of oncologic ne ...... ents. Results of the On study.
@en
First evidence of oncologic ne ...... ents. Results of the On study.
@nl
prefLabel
First evidence of oncologic ne ...... ents. Results of the On study.
@en
First evidence of oncologic ne ...... ents. Results of the On study.
@nl
P2093
P2860
P356
P1433
P1476
First evidence of oncologic ne ...... ents. Results of the On study.
@en
P2093
A Gascó Hernández
A L Ortega Granados
E Esteban González
E López Miranda
F J de Castro Carpeño
F del Moral González
J D Cumplido Burón
J L Martí Ciriquián
J P Ciria Santos
M Cobo Dols
P2860
P304
P356
10.1093/ANNONC/MDQ449
P577
2010-10-06T00:00:00Z